Vaxcyte, Inc. (PCVX) Misses Q4 EPS by 251c
Tweet
Share
E-mailGet Alerts PCVX Hot Sheet
Join SI Premium – FREE
Vaxcyte, Inc. (NASDAQ: PCVX) reported Q4 EPS of ($3.44), $2.51 worse than the analyst estimate of ($0.93).
For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Jefferies Downgrades Alfen (ALFEN:NA) (ALFNF) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
